Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
University of Texas at Austin · NCT05188079
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- October 1, 2021
- Record last updated
- January 16, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of the study is to assess vascular function in African Americans, Hispanic and Caucasian Americans to better understand racial differences in cardiovascular health. The investigators will further investigate the affect of Beetroot juice on the vascular function of all participants.
Being studied: Beetroot juice; Placebo drink
Conditions: Healthy Adults
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy men and women who are either Caucasian American, Hispanic, or non-Hispanic African American
Exclusion Criteria
- Blood pressure higher than or equal to 140/90 mmHg
- BMI > 35kg/m2
- Have a history of cardiovascular, neurological or vascular diseases
- Take prescription medications
- Are smokers
- Are pregnant
Recruiting US locations
University of Texas at Austin
Austin, TX 78712
Site contact: Jasdeep Kaur, PhD · 512-471-8595 · jasdeep.kaur@austin.utexas.edu
Study contacts (from the official record)
- jasdeep kaur, PhD · 5124718595 · jasdeep.kaur@austin.utexas.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75